Smurfit Westrock (NYSE:SW) is a top pick for the next 3 years, with Morgan Stanley raising the price target to
Immunovant Inc. (NASDAQ:IMVT) is a promising stock to buy under $50. Truist analyst raised price target to $22 on updated
HF Sinclair Corporation (NYSE:DINO) is a top pick among small-to-mid-cap refiners, with Piper Sandler upgrading it to Overweight with a
Ally Financial Inc. is a top pick for the next 3 years according to Bank of America and Cowen with
UWM Holdings Corporation (UWMC) is highlighted as a cheap stock to buy for the next 3 years, with a price
Mobileye Global Inc. (NASDAQ:MBLY) saw Piper Sandler lower its price target to $13 from $15, anticipating a divergent year for
Former Federal Reserve Chair Janet Yellen criticized an investigation into her successor, Jerome Powell, calling it a threat to the
Federal Reserve Chair Jerome Powell faces a criminal investigation over renovations at the Fed headquarters, sparking concerns about presidential influence
Bank of America predicts the Federal Reserve will keep interest rates steady through Powell’s tenure. Wall Street and Main Street’s
Indonesian President Prabowo Subianto inaugurates Pertamina’s upgraded Balikpapan refinery, boosting the country’s oil refining capacity. The $7.4bn upgrade managed by
Microchip Technology Incorporated, founded in 1989, is set to release its Q3 2026 earnings on Feb. 5. Analysts predict a
Fundsmith Equity Fund’s 2025 investor letter revealed 0.8% returns for T Class Accumulation shares, trailing the MSCI World Index’s 12.8%.
Fundsmith, a London-based investment firm, released its 2025 investor letter for the Fundsmith Equity Fund focusing on global equities. The
ClearBridge Investments released its fourth-quarter 2025 investor letter, reporting US equities had a strong but volatile performance. The strategy outperformed,
ClearBridge Investments released its fourth-quarter 2025 investor letter, noting a strong but volatile performance in US equities. The S&P 500
In an election year, Washington, D.C. focuses on Medicare Advantage oversight, with UnitedHealth Group under scrutiny for nursing home practices
Bristol-Myers Squibb (BMY) is a global biopharmaceutical company with a market cap of $113.7 billion, serving patients worldwide with leading
Bank executives, including CEOs of Wells Fargo, Bank of America, JPMorgan Chase, Citigroup, State Street, BNY Mellon, Goldman Sachs, and
ClearBridge Investments released its fourth-quarter 2025 investor letter, reporting US equities’ strong but volatile performance. The S&P 500 Index returned
Soybeans are gaining 5 to 6 cents ahead of the USDA report. Futures saw a slight dip from midday highs
Bristlemoon Global Fund’s fourth-quarter 2025 investor letter showed a -6.2% return in December and 0.3% return overall. Market trends favored
Bristlemoon Global Fund reported a -6.2% return in Q4 2025, with a 0.3% gain in December. The fund has a
Bristlemoon Global Fund’s fourth-quarter 2025 investor letter reported a -6.2% return in December and a 0.3% return for the month.
Crypto custody startup BitGo plans to raise up to $201 million in its U.S. IPO, offering 11.8 million shares priced
Federal Reserve Chair Jerome Powell faces scrutiny as the Justice Department investigates him for potential perjury charges. Sen. Thom Tillis
